22nd European Symposium on Quantitative Structure-Activity Relationship

The European Quantitative Structure-Activity Relationships (EuroQSAR) Symposia are major scientific events that have been organized in different cities of Europe since 1973. They have the fascinating scope to promote and disseminate advances in rational approaches in drug design and discovery and ensure a worldwide attendance of prominent scientists from both academia and industry.

The 22nd EuroQSAR 2018 symposium, entitled “Translational and Health Informatics: Implications for Drug Discovery” will focus on: 

  • ADME Prediction and Computational Toxicology for Safer and Efficacious Drugs
  • Big Data Analysis, Cloud Resources and Precision Medicine
  • Binding Kinetics in Drug Discovery
  • Biotechnology Targeted Drug Discovery
  • Cheminformatics / Pharmacoinformatics in the Era of Biological Complexity
  • Computational Biology and Quantum Enzymology
  • Computational Methods for Nanotechnology in Drug Discovery
  • Epigenetic Drug Targets
  • Homology Modelling for Drug Discovery
  • Ligand-Based and Structure-Based Approaches to Drug Design
  • Modelling of Natural Drugs
  • Molecular Dynamic Simulations and Related Methods
  • Multi-Targeting Drug Design
  • New avenues in QSAR Methodology and Applications
  • Protein Target Dynamics for Drug Discovery
  • Targeting Protein-Protein Interactions

Register now!

Abstract submission deadline for Oral Communictions : May 31, 2018

Abstract submission deadline for Poster Presentations : July 31, 2018

Early bird registration deadline : May 31, 2018

More information on the confirmed speakers and registration can be found on

Best regards,

EFMC Secretary

E-mail :


Thessaloniki, Greece
domingo, 16 Setembro, 2018 - 08:15 to quinta-feira, 20 Setembro, 2018 - 08:15